To confirm that the observed decrease in CCL2 expression was responsible for the reduced migration of monocytes towards TCM from GBM cells with reduced β-catenin expression, we added recombinant CCL2 (100 ng/mL) to β-catenin knockdown TCMs, which restored PBMC migration (Figure 2A). This evidence concerns the gene CCL2 and glioblastoma.